Thrombocytopenia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ochuko Ajari (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Line 4: | Line 5: | ||
Image = Thrombocytopenia 001.jpg| | Image = Thrombocytopenia 001.jpg| | ||
Caption = Marked thrombocytopenia and fragmented red blood cells.<br> <small> [http://www.peir.net Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology] </small>| | Caption = Marked thrombocytopenia and fragmented red blood cells.<br> <small> [http://www.peir.net Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology] </small>| | ||
{{Thrombocytopenia}} | {{Thrombocytopenia}} | ||
{{CMG}} | {{CMG}} |
Revision as of 18:37, 17 January 2014
For patient information click here {{Infobox_Disease |
Name = Thrombocytopenia | Image = Thrombocytopenia 001.jpg| Caption = Marked thrombocytopenia and fragmented red blood cells.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombocytopenia On the Web |
American Roentgen Ray Society Images of Thrombocytopenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thrombocytopenia from other Diseases
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies